Jun 5, 2020

Deloitte waives MyPath for Clinical fees for COVID-19 trials

Deloitte
William Girling
3 min
Deloitte
In a show of support and solidarity with the life sciences sector, Deloitte has reportedly waived licensing fees for its MyPath for Clinical platform...

In a show of support and solidarity with the life sciences sector, Deloitte has reportedly waived licensing fees for its MyPath for Clinical platform.

This is to ease the operational challenges experienced by those currently researching the COVID-19 virus in clinical trials.

A cloud-based digital platform, MyPath has been specifically designed to accelerate digital trials through improved engagement with patients, researchers and clinical associates via real-time data sharing and an intuitive user experience.

According to this latest update, any manufacturer in the pharmaceutical industry, academic research facility or other associated medical organisations will be granted full, unrestricted and free access to the platform until the end of August 2020 (up to and including the termination of any active COVID-19 trial).

Addressing new concerns in the industry

The highly contagious nature of coronavirus means that clinical trials must be scrupulously planned out and meticulously maintained to ensure patients receive optimal care.

Chris Zant, CDO for ConvergeHEALTH by Deloitte, said the company was determined to help address these new restrictions:

"COVID-19 has impacted the industry's ability to conduct trials with broad travel restrictions, concerns about investigative site capacity, and most importantly patient safety considerations.

"Deloitte is committed to helping our clients and society respond to this unprecedented situation."

MyPath’s holistic solution incorporates the latest cloud and mobile technology, enabling the platform to:

  • Personalise digital patient engagement.
  • Drive efficiency through data collection and analysis and improve the overall experience.
  • Provide support for trials across several locations.
  • Facilitate the development of further digital therapeutics.

Minimising operational interference

With clinical trials now required under strange new circumstances, MyPath can help to resolve three core challenges currently experienced by researchers:

  1. Patient recruitment: Often an expensive and ineffective process, MyPath employs AI and social media to help recruiters achieve quotas in a less costly fashion.
  2. Engagement to drive retention: Recognising the voluntary dropout of patients in clinical trials to be their most costly challenge, Deloitte employs gamification tactics, virtual trials and mobile health to make the process more ‘enjoyable’ for participants.
  3. Compliance: Following on from engagement, a patient-centric approach can incentivise adherence to trial protocols which can, in turn, improve the turnaround time of a pharmaceutical product from lab to market.

Ryan Hoffmeister, COO of ConvergeHEALTH, emphasised that Deloitte’s platform could provide organisations with a very effective way to minimise the operational interference of the virus:

"MyPath for Clinical is designed to help life sciences companies align with US and international regulatory bodies that have encouraged the adoption of remote data capture and 'siteless' trial capabilities to overcome these challenges and expedite needed solutions during the pandemic.

“Through this offer, we're hoping our clients and other qualifying organisations will be able to minimise the impact of COVID on their trials and move efficiently through the clinical trial process.”

Share article

Jun 13, 2021

Marketing matters: from IBM to Kyndryl

CMO
Kyndryl
IBM
Leadership
Kate Birch
5 min
Former CMO for IBM Americas Maria Bartolome Winans was recently named CMO for Kyndryl. Maria talks about her new role and her leadership style

Former Chief Marketing Officer for IBM Americas, and an IBM veteran of more than 25 years, Maria Bartolome Winans was recently named CMO for Kyndryl.

Prior to joining Kyndryl as Chief Marketing Officer, Maria had a 25-year career at IBM, most recently as the tech giant’s CMO where she oversaw all marketing professionals and activities across North America, Canada and Latin America. She has held senior global marketing positions in a variety of disciplines and business units across IBM, most notably strategic initiatives in Smarter Cities and Watson Customer Engagement, as well as leading teams in services, business analytics, and mobile and industry solutions. She is known for her work with teams to leverage data, analytics and cloud technologies to build deeper engagements with customers and partners.

With a passion for marketing, business and people, and a recognized expert in data-driven marketing and brand engagement, Maria talks to Business Chief about her new role, her leadership style and what success means to her.

You've recently moved from IBM to Kyndryl, joining as CMO. Tell us about this exciting new role?

I’m Chief Marketing Officer for Kyndryl, the independent company that will be created following the separation from IBM of its Managed Infrastructure Services business, expected to occur by the end of 2021. My role is to plan, develop, and execute Kyndryl's marketing and advertising initiatives. This includes building a company culture and brand identity on which we base our marketing and advertising strategy.

We have an amazing opportunity ahead at Kyndryl to create a company brand that will stand apart in the market by leading with our people first. Once we are an independent company, each Kyndryl employee will advance the vital systems that power human progress. Our people are devoted, restless, empathetic, and anticipatory – key qualities needed as we build on existing customer relationships and cultivate new ones. Our people are at the heart of this business and I am deeply hopeful and excited for our future.

What experiences have helped prepare you for this new opportunity?

I’ve had a very rich and diverse career history at IBM that has lasted 25+ years. I started out in sales but landed explored opportunities at IBM in different roles, business units, geographies, and functions. Marketing and business are my passions and I landed on Marketing because it allowed me to utilize both my left and right brain, bringing together art and science. In college, I was no tonly a business major, but an art major. I love marketing because I can leverage my extensive knowledge of business, while also being able to think openly and creatively.

The opportunities I was given during my time at IBM and my natural curiosity have led me to the path I’m on now and there’s no better next career step than a once-in-a-lifetime-opportunity to help launch a company. The core of my role at Kyndryl is to create a culture centered on our people and growing up in my career at IBM has allowed me to see first-hand how to prioritize people and ensure they are at the heart of progress in everything Kyndryl will do.

How would you describe your leadership style?

I believe that people aren't your greatest assets, they are your only assets. My platform and background for leadership has always been grounded in authenticity to who I am and centered on diversity and inclusion. I immigrated to the US from Chile when I was 10 years old and so I know the power and beauty that comes from leaning into what makes you different from other people, and that's what I want every person in my marketing organization to feel – the value in bringing their most authentic self to work every day. The way our employees feel when they show up for themselves authentically is how they will also show up for our customers, and strong relationships drive growth.

I think this is especially true in light of a world forever changed by the pandemic. Living through such an unprecedented time has reinforced that we are all humans. We can't lead or care for one another without empathy and I think leaders everywhere have been reminded of this.

What’s the best leadership advice you’ve received?

When I was growing up as an immigrant in North Carolina, I often wanted to be just like everyone else. But my mother always told me: Be unique, be memorable – you have an authentic view and experience of the world that no one else will ever have, so don't try to be anyone else but you.

What does success look like to you?

I think the concept of success is multi-faceted. From a career perspective, being in a job where you're respected and appreciated, and where you can see how your contributions are providing value by motivating your teams to be better – that's success! From a personal perspective, there is no greater accomplishment than investing in the next generation. I love mentoring younger professionals – they are the future. I want my legacy as a leader to include providing value in work culture, but also in leaving a personal impact on the lives of professionals who will carry the workforce forward. Finding a position in life with a job and company that offers me a chance at all of that is what success looks like to me.

What advice would you give to your younger self just starting out in the industry?

I've always been a naturally curious person and it's easy for me to over-commit to projects that pique my interest. I've learned over years of practice how to manage that, so to my younger self I’d say… prioritize the things that are most important, and then become amazing at those things.

Share article